India’s Pharma Exports Face High Risk Amid US Tariff
India’s pharmaceutical sector is staring at heightened uncertainty following US President Donald Trump’s recent increased tariff on Indian goods. On…
Piramal Pharma
Read More
Piramal Pharma and Aster DM Healthcare Soar to New Heights: A Promising Future for Investors
Piramal Pharma, Aster DM Healthcare, and Others Reach 52-Week Highs: What This Means for Investors piramal pharma, along with several…